ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1822

RNA-Sequencing of Mouse and Human Synovial Fibroblasts Reveals Fibroblast Subset-Specific Responses to Inflammation

Anqi Gao1, Kevin Wei2, Ilya Korsunsky3 and Michael Brenner4, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Division of Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibroblasts

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: 4M085 ACR Abstract: RA–Animal Models (1822–1827)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: In rheumatoid arthritis (RA), synovial fibroblasts secrete inflammatory cytokines, degrade cartilage and mediate bone destruction. We have previously identified three synovial fibroblasts subsets with distinct transcriptomic profiles. However, whether synovial fibroblast subsets exhibit differential effector functions during inflammatory arthritis remains unclear. Here, we sought to determine if fibroblast subsets display unique or shared effector functions using a K/BxN serum transfer arthritis model in mice.

Methods: Synovial tissue was isolated from bilateral knees of normal, non-arthritic mice (n = 25) or mice after K/BxN serum transfer (n = 35). Following enzymatic digestion, synovial fibroblasts were divided into three fibroblast subsets: CD90+, CD90-CAD11+, and CD90-CAD11-. In parallel, we isolated human synovial fibroblast subsets (CD90+C34+, CD90+CD34-, and CD90-) from RA and OA (n=10) synovial tissue. Transcriptomic profiles were generated using 1000 cells from each fibroblast subset by Smart-Seq2. Synovial leukocyte (CD45+) infiltration for each tissue sample was determined by flow cytometry to identify inflamed samples (>45% leukocytes).

Results:

  1. CD90+ fibroblast subset corresponds to sublining fibroblasts in mice. Principal component analysis using the top 3000 most variable genes identified distinct transcriptomic profiles among mouse fibroblasts subsets sorted based on expression of CD90 and CAD11. Consistent with synovial lining fibroblasts, lining markers PRG4 and FN1 were significantly upregulated in CD90- fibroblasts (p<9.1e-5 and p<3.84e-6, respectively). In contrast, sublining markers CD34 and MFAP5 were highly expressed by CD90+ fibroblasts. PCA of human synovial fibroblast subsets separates lining from sublining fibroblast subsets, suggesting conserved subsets between human and mouse.
  2. Lining and sublining fibroblasts exhibit markedly distinct responses in the setting of serum transfer arthritis. We identified 999, 537, and 122 significantly upregulated genes (P<0.0088) in CD90-CAD11+ lining fibroblasts, CD90-CAD11- lining fibroblasts, and sublining fibroblasts, respectively. While there were many genes that were significantly up-regulated by both CD90-CAD11+ and CD90-CAD11- subsets (61), there were only a few that were up-regulated by both CD90+ and CD90-CAD11+ (9) as well as CD90+ and CD90-CAD11- (2). Remarkably, no genes were significantly up-regulated by all three fibroblast subsets, suggesting lining and sublining fibroblasts exhibit unique responses to serum transfer induced arthritis.

Conclusion:

Transcriptomic profiling of mouse and human synovial fibroblasts reveals distinct lining and sublining fibroblasts subsets. During inflammatory arthritis, synovial fibroblasts exhibit distinct subset-specific responses to inflammation, suggesting they play different pathologic roles in arthritis.


Disclosure: A. Gao, None; K. Wei, None; I. Korsunsky, None; M. Brenner, Roche, 2.

To cite this abstract in AMA style:

Gao A, Wei K, Korsunsky I, Brenner M. RNA-Sequencing of Mouse and Human Synovial Fibroblasts Reveals Fibroblast Subset-Specific Responses to Inflammation [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/rna-sequencing-of-mouse-and-human-synovial-fibroblasts-reveals-fibroblast-subset-specific-responses-to-inflammation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rna-sequencing-of-mouse-and-human-synovial-fibroblasts-reveals-fibroblast-subset-specific-responses-to-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology